戻る Agendas
Session 0906 Innovative Approaches to Ensuring Quality in Clinical Trials and Compliance to GCP
Session Chair(s)
Deborah Driscoll, MS
Vice President, MRL Quality Assurance
Merck & Co., Inc., United States
Speaker(s)
Ann Meeker-O'Connell, MS
Novartis, United States
Executive Director, Monitoring Excellence Head
Trial-Level Quality approach highlighting TransCelerate’s model approach to RBM (EN&CN).pdf
Brett Wilson
Pfizer Inc, Canada
Senior Director, Global Biometrics and Data Management
Gongtao Lan
CFDA - Registration, China
Jianan Wang
CCD, CFDA, China
Assistant Pharmacist